Blog

Introduction Irritable bowel syndrome with constipation (IBS-C) is a complex disorder of gut-brain interaction that frustrates nearly 10-15% of the glob…

Autologous Fecal Transplant Accelerates Microbiome Recovery in Horses Antibiotics can save lives, but they also indiscriminately destroy the complex mic…

Emerging Pathophysiology-Based Strategies for IBS-C Irritable bowel syndrome with constipation, or IBS-C, is more than a problem of slow motility

Introduction Irritable Bowel Syndrome with constipation (IBS-C) presents a persistent challenge characterized by abdominal pain and infrequent, difficul…

IBS-C Constipation Treatment Management: A 2026 Research Update Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where abdominal…

Treating IBS-C Beyond Laxatives: New Insights from Pathophysiology and Meal Timing A 2026 review article by Mohamed et al

Pathophysiology-Driven IBS-C Management: New Insights on Natural Products and Timing Irritable bowel syndrome with constipation affects an estimated 5% …

Introduction Irritable bowel syndrome with constipation (IBS-C) is more than just infrequent bowel movements

Beyond the Laxative: A Pathophysiology-Driven Approach to IBS-C Management Irritable bowel syndrome with constipation (IBS-C) is more than slow transit

IBS-C Constipation Treatment Management: Pathophysiology and Natural Interventions Irritable bowel syndrome with constipation (IBS-C) remains a complex …

Evidence-Based IBS-C Management: Moving Beyond Symptom Relief Irritable Bowel Syndrome with Constipation (IBS-C) is characterized by abdominal pain and …

An Evidence-Based Approach to Managing IBS-C Irritable bowel syndrome with constipation affects approximately one in every twenty adults globally, makin…